A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people

Annals of Pharmacotherapy

Volumn 44, Issue 11, 2010, Pages 1725-1732

  Gnjidic, Danijela ^a   Le Couteur, David G ^b   Abernethy, Darrell R ^c   Hilmer, Sarah N ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anticholinergic and sedative medications; Older adults; Prescribing practices

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BRONCHODILATING AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT; SPASMOLYTIC AGENT;

AGED; ARTICLE; AUSTRALIA; CALCULATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EXPOSURE; DURG BURDEN INDEX; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CHOLINERGIC ANTAGONISTS; CLUSTER ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTITIONERS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NEW SOUTH WALES; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS;

EID: 78049486059     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P310     Document Type: Article

References (29)

1. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009;85:86-8. DOI 10.1038/clpt.2008.224
2. Barry PJ, Gallagher P, Ryan C. Inappropriate prescribing in geriatric patients. Curr Psychiatry Rep 2008;10:37-43. DOI 10.1007/s11920-008-0008-3
3. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24. DOI 10.1001/archinte.163.22.2716
4. Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005;60:622-6. DOI 10.1093/gerona/60.5.622
5. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003;163:949-57.
6. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007;81:235-41. DOI 10.1038/sj.clpt.6100035
7. Carriere I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 2009;169:1317-24. DOI 10.1001/archinternmed.2009.229
8. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008;25:1021-31. DOI 10.2165/0002512-200825120-00004
9. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999;47:850-3.
10. van der Velde N, Stricker BH, Pols HA, van der Cammen TJ. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol 2007;63:232-7. DOI 10.1111/j.1365-2125.2006.02736.x
11. van der Velde N, Stricker BH, Pols HA, van der Cammen TJ. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007;24:691-9.
12. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007;167:781-7.
13. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008;83:422-9. DOI 10.1038/sj.clpt.6100303
14. Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009;68:97-105. DOI 10.1111/j.1365-2125.2009.03411.x
15. Hilmer SN, Mager DE, Simonsick EM, et al. Drug burden index score and functional decline in older people. Am J Med 2009;122:1142-9 e1-2. DOI 10.1016/j.amjmed.2009.02.021
16. Donohoo E. MIMS Annual 2008. Donohoo E, ed. Sydney, Australia: CMPMedica Australia; 2008.
17. National Prescribing Service. 2010. www.nps.org.au/home (accessed 2010 Jan 11).
18. Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA. A quality use of medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007;187:23-30.
19. Robertson J, Treloar CJ, Sprogis A, Henry DA. The influence of specialists on prescribing by GPs. A qualitative study. Aust Fam Physician 2003;32:573-6.
20. Weekes LM, Mackson JM, Fitzgerald M, Phillips SR. National Prescribing Service: creating an implementation arm for national medicines policy. Br J Clin Pharmacol 2005;59:112-6. DOI 10.1111/j.1365-2125.2005.02231.x
21. Chen FW, Hilmer SN. Exposure of geriatric medicine patients to medications with anticholinergic and sedative effects. Presented at: 41st Scientific Meeting, Australian Society of Clinical and Experimental Pharmacology and Toxicology Annual Meeting, Adelaide, South Australia, December 5, 2007.
22. Orzella L, Chini F, Giorgi Rossi P, Borgia P. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy. Health Policy 2010;95:236-44. DOI 10.1016/j.healthpol.2009.12. 005
23. Carrin G. Drug prescribing: a discussion of its variability and (ir)rationality. Health Policy 1987;7:73-94.
24. Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J. Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care 2003;41:895-908. DOI 10.1097/01.MLR.0000078145. 41828.3E
25. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84. DOI 10.1016/S0140-6736(07)61091-5
26. Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging 2009;26:677-86. DOI 10.2165/11316440-000000000-00000
27. Stevenson FA, Greenfield SM, Jones M, Nayak A, Bradley CP. GPs' perceptions of patient influence on prescribing. Fam Pract 1999;16:255-61.
28. Lau DT, Briesacher BA, Mercaldo ND, et al. Older patients' perceptions of medication importance and worth: an exploratory pilot study. Drugs Aging 2008;25:1061-75. DOI 10.2165/0002512-200825120-00007
29. Donohue JM, Huskamp HA, Wilson IB, Weissman J. Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother 2009;7:105-16. DOI 10.1016/j.amjopharm.2009.04.005